npc 12626 has been researched along with vanoxerine in 1 studies
Studies (npc 12626) | Trials (npc 12626) | Recent Studies (post-2010) (npc 12626) | Studies (vanoxerine) | Trials (vanoxerine) | Recent Studies (post-2010) (vanoxerine) |
---|---|---|---|---|---|
55 | 0 | 0 | 556 | 5 | 93 |
Protein | Taxonomy | npc 12626 (IC50) | vanoxerine (IC50) |
---|---|---|---|
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.5098 | |
Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.0103 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 1.5513 | |
Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.0969 | |
Small conductance calcium-activated potassium channel protein 2 | Rattus norvegicus (Norway rat) | 0.073 | |
Small conductance calcium-activated potassium channel protein 3 | Rattus norvegicus (Norway rat) | 0.073 | |
Small conductance calcium-activated potassium channel protein 1 | Rattus norvegicus (Norway rat) | 0.073 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.0424 | |
Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.022 | |
Transporter | Rattus norvegicus (Norway rat) | 0.114 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Edwards, MA; Kantak, KM; Kitchel, E; Wilcox, KM | 1 |
1 other study(ies) available for npc 12626 and vanoxerine
Article | Year |
---|---|
Discriminative stimulus effects of magnesium chloride: substitution studies with monoamine uptake inhibitors and N-methyl-D-aspartate antagonists.
Topics: Amino Acids; Animals; Discrimination Learning; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Magnesium Chloride; Male; Neurotransmitter Uptake Inhibitors; Piperazines; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate | 1997 |